HYDREA 830 HYDREA 830 (Hydrea 500 mg)
Generic Name: hydroxyurea
Pill imprint HYDREA 830 HYDREA 830 has been identified as Hydrea 500 mg.
Hydrea is used in the treatment of anemia, sickle cell; chronic myelogenous leukemia; solid tumors and belongs to the drug class antimetabolites. There is positive evidence of human fetal risk during pregnancy. Hydrea 500 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for HYDREA 830 HYDREA 830
- Generic Name:
- 500 mg
- Pink & Turquoise
- 22.00 mm
- Prescription only
- Drug Class:
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Bristol-Myers Squibb
- National Drug Code (NDC):
- Inactive Ingredients:
- citric acid monohydrate
D&C Yellow No. 10
FD&C Blue No. 1
FD&C Red No. 40
D&C Red No. 28
|NDC Code||Manufacturer / Repackager|
|54868-1367||Physicians Total Care Inc (repackager)|
Note: Inactive ingredients may vary.
More about Hydrea (hydroxyurea)
- Other brands: Droxia
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.